Analyte monitoring device and methods of use
CA 2433144 C · Owner: Abbott Diabetes Care Inc. · Inventors: Heller, Adam; Jin, Robert Y.; Funderburk, Jeffery V.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An analyte monitor includes a sensor (42) a sensor control unit (44), and a , display unit (48). The sensor (42) has for example, a substrate, a recessed , chanel formed in the substrate and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit (44) typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit (44) also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 28, 2001 and granted February 3, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 28, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 28, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.